Skip to main content
Top
Published in: BMC Pediatrics 1/2013

Open Access 01-12-2013 | Research article

Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence

Authors: Roberta H Richey, Utpal U Shah, Matthew Peak, Jean V Craig, James L Ford, Catrin E Barker, Anthony J Nunn, Mark A Turner

Published in: BMC Pediatrics | Issue 1/2013

Login to get access

Abstract

Background

A lack of age-appropriate formulations can make it difficult to administer medicines to children. A manipulation of the dosage form may be required to achieve the required dose. This study aimed to describe medicines that are manipulated to achieve the required dose in paediatric practice.

Method

A structured, undisguised observational study and postal survey. The observational study investigated drug manipulations occurring in clinical practice across three sites. The questionnaire, administered to a sample of paediatric nurses throughout the UK, surveyed manipulations conducted and nurses’ experiences and views.

Results

The observational study identified 310 manipulations, of which 62% involved tablets, 21% were intravenous drugs and 10% were sachets. Of the 54 observed manipulations 40 involved tablets with 65% of the tablets being cut and 30% dispersed to obtain a smaller dose. 188 manipulations were reported by questionnaire respondents, of these 46% involved tablets, 12% were intravenous drugs, and 12% were nebuliser solutions. Manipulations were predominantly, but not exclusively, identified in specialist clinical areas with more highly dependent patients. Questionnaire respondents were concerned about the accuracy of the dose achieved following manipulations and the lack of practice guidance.

Conclusion

Manipulations to achieve the required dose occur throughout paediatric in-patient settings. The impact of manipulations on the efficacy of the drugs, the accuracy of the dose and any adverse effects on patients is not known. There is a need to develop evidence-based guidance for manipulations of medicines in children.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kayitare E, Vervaet C, Ntawukulilyayo JD, Seminega B, Bortel V, Remon JP: Development of fixed dose combination tablets containing zidovudine and lamivudine for paediatric applications. Int J Pharm. 2009, 370: 41-49. 10.1016/j.ijpharm.2008.11.005.CrossRefPubMed Kayitare E, Vervaet C, Ntawukulilyayo JD, Seminega B, Bortel V, Remon JP: Development of fixed dose combination tablets containing zidovudine and lamivudine for paediatric applications. Int J Pharm. 2009, 370: 41-49. 10.1016/j.ijpharm.2008.11.005.CrossRefPubMed
2.
go back to reference Fontan JE, Mille F, Brion F: Drug administration to paediatric patients. Arch Pediatr. 2004, 11: 1173-1184. 10.1016/j.arcped.2004.06.024.CrossRefPubMed Fontan JE, Mille F, Brion F: Drug administration to paediatric patients. Arch Pediatr. 2004, 11: 1173-1184. 10.1016/j.arcped.2004.06.024.CrossRefPubMed
4.
go back to reference Nahata MC: Lack of pediatric drug formulations. Pediatrics. 1999, 104: 607-609.PubMed Nahata MC: Lack of pediatric drug formulations. Pediatrics. 1999, 104: 607-609.PubMed
5.
go back to reference Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, Knoeppel C, Seyberth H, Pandolfini C, Raffaelli MP, Rocchi F, Bomati M, Jong G, de Hoog M, van den Anker J: Survey of unlicensed and off label use in paediatric wards in European countries. European Network for Drug Investigation in Children. Br Med J. 2000, 320: 79-82. 10.1136/bmj.320.7227.79.CrossRef Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, Knoeppel C, Seyberth H, Pandolfini C, Raffaelli MP, Rocchi F, Bomati M, Jong G, de Hoog M, van den Anker J: Survey of unlicensed and off label use in paediatric wards in European countries. European Network for Drug Investigation in Children. Br Med J. 2000, 320: 79-82. 10.1136/bmj.320.7227.79.CrossRef
6.
go back to reference Rocchi F, Tomasi P: The development of medicines for children. Pharmacol Res. 2011, 64: 169-175. 10.1016/j.phrs.2011.01.016.CrossRefPubMed Rocchi F, Tomasi P: The development of medicines for children. Pharmacol Res. 2011, 64: 169-175. 10.1016/j.phrs.2011.01.016.CrossRefPubMed
7.
go back to reference Standing JF, Tuleu C: Paediatric formulations – Getting to the heart of the problem. Int J Pharm. 2005, 300: 56-66. 10.1016/j.ijpharm.2005.05.006.CrossRefPubMed Standing JF, Tuleu C: Paediatric formulations – Getting to the heart of the problem. Int J Pharm. 2005, 300: 56-66. 10.1016/j.ijpharm.2005.05.006.CrossRefPubMed
8.
go back to reference Verrue C, Mehuys E, Boussery K, Remon JP, Petrovic M: Tablet splitting: a common yet not so innocent practice. J Adv Nurs. 2011, 67: 26-32. 10.1111/j.1365-2648.2010.05477.x.CrossRefPubMed Verrue C, Mehuys E, Boussery K, Remon JP, Petrovic M: Tablet splitting: a common yet not so innocent practice. J Adv Nurs. 2011, 67: 26-32. 10.1111/j.1365-2648.2010.05477.x.CrossRefPubMed
9.
go back to reference Skwierczynski C, Conroy S: How long does it take to administer oral medicines to children?. Paediatric Perinatal Drug Therapy. 2008, 8: 145-149. 10.1185/146300908X254206.CrossRef Skwierczynski C, Conroy S: How long does it take to administer oral medicines to children?. Paediatric Perinatal Drug Therapy. 2008, 8: 145-149. 10.1185/146300908X254206.CrossRef
10.
go back to reference Conroy S, Sweis D, Planner C, Yeung V, Collier J, Haines L, Wong IC: Interventions to reduce dosing errors in children: a systematic review of the literature. Drug Saf. 2007, 30: 1111-1125. 10.2165/00002018-200730120-00004.CrossRefPubMed Conroy S, Sweis D, Planner C, Yeung V, Collier J, Haines L, Wong IC: Interventions to reduce dosing errors in children: a systematic review of the literature. Drug Saf. 2007, 30: 1111-1125. 10.2165/00002018-200730120-00004.CrossRefPubMed
11.
go back to reference Sayeed VA, Gupta A, Khan MA: Stability of split tablets. Chpt 20. Pharmaceutical Stability Testing to Support Global Markets. Edited by: Huynh-Ba K. 2010, New York: American Association of Pharmaceutical Scientists Sayeed VA, Gupta A, Khan MA: Stability of split tablets. Chpt 20. Pharmaceutical Stability Testing to Support Global Markets. Edited by: Huynh-Ba K. 2010, New York: American Association of Pharmaceutical Scientists
12.
go back to reference Quinzler R, Gasse C, Scheider A, Kaufmann-Kolle P, Szecsenyi J, Haefeli WE: The frequency of inappropriate tablet splitting in primary care. Eur J Clin Pharmacol. 2006, 12: 1065-1073.CrossRef Quinzler R, Gasse C, Scheider A, Kaufmann-Kolle P, Szecsenyi J, Haefeli WE: The frequency of inappropriate tablet splitting in primary care. Eur J Clin Pharmacol. 2006, 12: 1065-1073.CrossRef
13.
go back to reference Richey RH, Craig JV, Shah UU, Ford JL, Barker CE, Peak M, Nunn AJ, Turner MA: The manipulation of drugs to obtain the required dose: systematic review. J Adv Nurs. 2012, 68: 2103-2112. 10.1111/j.1365-2648.2011.05916.x.CrossRefPubMed Richey RH, Craig JV, Shah UU, Ford JL, Barker CE, Peak M, Nunn AJ, Turner MA: The manipulation of drugs to obtain the required dose: systematic review. J Adv Nurs. 2012, 68: 2103-2112. 10.1111/j.1365-2648.2011.05916.x.CrossRefPubMed
14.
go back to reference Nunn AJ, Richey RH, Shah UU, Barker CE, Craig JV, Peak M, Ford JL, Turner MA: Estimating the requirement for manipulation of medicines to provide accurate doses for children. Eur J Hospital Pharm. 2013, 20: 3-7.CrossRef Nunn AJ, Richey RH, Shah UU, Barker CE, Craig JV, Peak M, Ford JL, Turner MA: Estimating the requirement for manipulation of medicines to provide accurate doses for children. Eur J Hospital Pharm. 2013, 20: 3-7.CrossRef
15.
go back to reference Hill SW, Varker AS, Karlage K, Myrdal PB: Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications. J Manag Care Pharm. 2009, 15: 253-261.PubMed Hill SW, Varker AS, Karlage K, Myrdal PB: Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications. J Manag Care Pharm. 2009, 15: 253-261.PubMed
16.
go back to reference van Santen E, Barends DM, Frijlink HW: Breaking of scored tablets: a review. Eur J Pharm Biopharm. 2002, 53: 139-145. 10.1016/S0939-6411(01)00228-4.CrossRefPubMed van Santen E, Barends DM, Frijlink HW: Breaking of scored tablets: a review. Eur J Pharm Biopharm. 2002, 53: 139-145. 10.1016/S0939-6411(01)00228-4.CrossRefPubMed
17.
go back to reference Shah RB, Collier JS, Sayeed VA, Bryant A, Habib MJ, Khan MA: Tablet splitting of a narrow therapeutic index drug: a case with levothyroxine sodium. AAPS Pharm Sci Tech. 2010, 11: 1359-1367. 10.1208/s12249-010-9515-8.CrossRef Shah RB, Collier JS, Sayeed VA, Bryant A, Habib MJ, Khan MA: Tablet splitting of a narrow therapeutic index drug: a case with levothyroxine sodium. AAPS Pharm Sci Tech. 2010, 11: 1359-1367. 10.1208/s12249-010-9515-8.CrossRef
18.
go back to reference Broadhurst EC, Ford JL, Nunn AJ, Rowe PH, Roberts M: Dose uniformity of samples prepared from dispersible aspirin tablets for paediatric use. Eur J Hospital Pharm Sci. 2008, 14: 27-31. Broadhurst EC, Ford JL, Nunn AJ, Rowe PH, Roberts M: Dose uniformity of samples prepared from dispersible aspirin tablets for paediatric use. Eur J Hospital Pharm Sci. 2008, 14: 27-31.
19.
go back to reference BNF for Children [2008/2009]. Edited by: Paediatric Formulary Committee. 2008/2009, London: BMJ Group, Pharmaceutical Press, and RCPCH Publications BNF for Children [2008/2009]. Edited by: Paediatric Formulary Committee. 2008/2009, London: BMJ Group, Pharmaceutical Press, and RCPCH Publications
Metadata
Title
Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence
Authors
Roberta H Richey
Utpal U Shah
Matthew Peak
Jean V Craig
James L Ford
Catrin E Barker
Anthony J Nunn
Mark A Turner
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2013
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/1471-2431-13-81

Other articles of this Issue 1/2013

BMC Pediatrics 1/2013 Go to the issue